Rosuvastatin Terminated Phase 4 Trials for Atherosclerosis / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00673582Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients
NCT02114697Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging